$RSII READ THIS NOW, ESPECIALLY THE LAST PARAGRAPH! FROM STOCKROCKET!!!
ALL READ THIS>RSII business model imo:
I should know... Im in the pharmaceutical industry as mgr with a big pharma co.
"Our team has met with business operators that have real experience and expertise in multiple states and several business verticals within the cannabis industry," commented Management. "The business focus will center on working with physicians and pharmacists groups on the Research and Development of new, cutting edge treatments within the medical cannabis industry. Shareholders are encouraged to stay tuned to upcoming press releases and social media updates, where a detailed plan for RSII's entrance into this sector will be outlined."
Look & Listen at the video on Facebook with outside one of the labs of a compounding pharmacy: https://www.facebook.com/RisingIndiaUSA/?hc_r...mp;fref=nf
1- What is “compounding”?
In general, compounding is a practice in which a licensed pharmacist, a licensed physician, or, in the case of an outsourcing facility, a person under the supervision of a licensed pharmacist, combines, mixes, or alters ingredients of a drug to create a medication tailored to the needs of an individual patient.
2-Why do some patients need compounded drugs?
Sometimes, the health needs of a patient cannot be met by an FDA-approved medication. For example: if a patient has an allergy and needs a medication to be made without a certain dye; or
if an elderly patient or a child can’t swallow a pill and needs a medicine in a liquid form that is not otherwise available.
3-Are compounded drugs approved by the FDA?
Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, or effectiveness of compounded drugs. Consumers and health professionals rely on the drug approval process to ensure that drugs are safe and effective and made in accordance with Federal quality standards. Compounded drugs also lack an FDA finding of manufacturing quality before such drugs are marketed.
Generally, state boards of pharmacy will continue to have primary responsibility for the day-to-day oversight of state-licensed pharmacies that compound drugs in accordance with the conditions of section 503A of the FDCA, although FDA retains some authority over their operations. However, outsourcing facilities that register under section 503B are regulated by FDA and must comply with CGMP requirements and will be inspected by FDA according to a risk-based schedule.
NOW...OWCP is a pharmaceutical co....that route is so much riskier and cost millions and millions of dollars to do studies and submit to FDA for approval....MOST get denied or fail phase 1 and 2 studies....RSII model has a different set of regulations that are PERFECT for the medical cannabis industry....Revs are instant and their are no FDA guidleines...This is going to be huge...very huge.
ALL READ THIS>RSII business model imo:
I should know... Im in the pharmaceutical industry as mgr with a big pharma co.
"Our team has met with business operators that have real experience and expertise in multiple states and several business verticals within the cannabis industry," commented Management. "The business focus will center on working with physicians and pharmacists groups on the Research and Development of new, cutting edge treatments within the medical cannabis industry. Shareholders are encouraged to stay tuned to upcoming press releases and social media updates, where a detailed plan for RSII's entrance into this sector will be outlined."
Look & Listen at the video on Facebook with outside one of the labs of a compounding pharmacy: https://www.facebook.com/RisingIndiaUSA/?hc_r...mp;fref=nf
1- What is “compounding”?
In general, compounding is a practice in which a licensed pharmacist, a licensed physician, or, in the case of an outsourcing facility, a person under the supervision of a licensed pharmacist, combines, mixes, or alters ingredients of a drug to create a medication tailored to the needs of an individual patient.
2-Why do some patients need compounded drugs?
Sometimes, the health needs of a patient cannot be met by an FDA-approved medication. For example: if a patient has an allergy and needs a medication to be made without a certain dye; or
if an elderly patient or a child can’t swallow a pill and needs a medicine in a liquid form that is not otherwise available.
3-Are compounded drugs approved by the FDA?
Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, or effectiveness of compounded drugs. Consumers and health professionals rely on the drug approval process to ensure that drugs are safe and effective and made in accordance with Federal quality standards. Compounded drugs also lack an FDA finding of manufacturing quality before such drugs are marketed.
Generally, state boards of pharmacy will continue to have primary responsibility for the day-to-day oversight of state-licensed pharmacies that compound drugs in accordance with the conditions of section 503A of the FDCA, although FDA retains some authority over their operations. However, outsourcing facilities that register under section 503B are regulated by FDA and must comply with CGMP requirements and will be inspected by FDA according to a risk-based schedule.
NOW...OWCP is a pharmaceutical co....that route is so much riskier and cost millions and millions of dollars to do studies and submit to FDA for approval....MOST get denied or fail phase 1 and 2 studies....RSII model has a different set of regulations that are PERFECT for the medical cannabis industry....Revs are instant and their are no FDA guidleines...This is going to be huge...very huge.
